Position in AGEN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$176,427
+$94,597 QoQ
Shares Held
57,656
+135.3% QoQ
Ownership
0.128%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 103 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGEN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRICE T ROWE ASSOCIATES INC /MD/ holds $17,555,962,932 across 304 Biotechnology names. AGEN ranks #259 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,678,047 | $2,484,611,664 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,529,709 | $953,834,749 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,728,421 | $858,558,562 | |
| 4 | KYMR |
Kymera Therapeutics, Inc.
|
7,112,980 | $815,645,416 | |
| 5 | RPRX |
Royalty Pharma plc
|
11,193,657 | $627,628,347 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
2,969,853 | $447,655,945 | |
| 7 | MRNA |
Moderna, Inc.
|
5,589,560 | $391,436,886 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
6,794,837 | $373,716,035 |
All Filings in AGEN
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $176,427 | 57,656 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $81,830 | 24,500 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $76,930 | 24,500 | Shares | Defined | 2026-02-17 | |
| 2025-03-31 | $15,184 | 10,056 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $115,474 | 21,072 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $349,086 | 20,841 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $207,590 | 357,915 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $194,931 | 234,857 | Shares | Defined | 2024-02-16 | |
| 2023-09-30 | $255,375 | 225,996 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $315,321 | 197,076 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $278,587 | 183,281 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $458,133 | 190,889 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $376,172 | 183,499 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $316,363 | 163,074 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $329,711 | 134,029 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $390,608 | 121,307 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $234,066 | 44,584 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $245,315 | 44,684 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $104,110 | 38,276 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $119,720 | 37,648 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $4,793,249 | 1,198,313 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $7,343,247 | 1,868,512 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $169,549 | 69,204 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||